Eastern Mediterranean (WHO region) vs United States of America: Treatment success rate: XDR-TB cases

Eastern Mediterranean (WHO region)
74
in 2022
United States of America
100
in 2021
Eastern Mediterranean (WHO region) rank
1st
United States of America rank
1st

Treatment success rate: XDR-TB cases over time

  • Eastern Mediterranean (WHO region)
  • United States of America
020406080100200820152022

How they compare

United States of America currently reports 100 against 74 in Eastern Mediterranean (WHO region), a difference of 26.

That makes United States of America's figure about 1.4 times Eastern Mediterranean (WHO region)'s.

The two have swapped places 5 times across 10 shared years of data; in 2010 it was Eastern Mediterranean (WHO region) ahead.

Eastern Mediterranean (WHO region) ranks 1st and United States of America ranks 1st of 11 groups.

Across the 2 decades both report, Eastern Mediterranean (WHO region) averaged higher in 1 and United States of America in 1.

Head to head by decade

Decade Eastern Mediterranean (WHO region) United States of America Difference Ahead
2010s 41.25 68.5 27.25 United States of America
2020s 71 50 21 Eastern Mediterranean (WHO region)

Averages of every year both report within each decade.

Frequently asked questions

Which has higher treatment success rate: xdr-tb cases, Eastern Mediterranean (WHO region) or United States of America?
United States of America, at 100 against 74 in Eastern Mediterranean (WHO region) as of 2021.
What is the difference in treatment success rate: xdr-tb cases between Eastern Mediterranean (WHO region) and United States of America?
26, with United States of America ahead.
How many years of comparable data are there for Eastern Mediterranean (WHO region) and United States of America?
10 years are reported by both, from 2010 to 2021.
How do Eastern Mediterranean (WHO region) and United States of America rank globally for treatment success rate: xdr-tb cases?
Eastern Mediterranean (WHO region) ranks 1st and United States of America ranks 1st of 11 groups.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Treatment success rate: XDR-TB cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Eastern Mediterranean (WHO region) vs United States of America: Treatment success rate: XDR-TB cases. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 15 September 2026, from https://health.statizoid.com/compare/treatment-success-rate-xdr-tb-cases/eastern-mediterranean-who-region/united-states/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/treatment-success-rate-xdr-tb-cases/eastern-mediterranean-who-region/united-states/">Eastern Mediterranean (WHO region) vs United States of America: Treatment success rate: XDR-TB cases</a> — Statizoid

About this data

Indicator
Treatment success rate: XDR-TB cases
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
93 places, 901 data points, 2008–2022
Last refreshed